Insulin Stimulates IL-23 Expression in Human Adipocytes: A Possible Explanation for the Higher Prevalence of Psoriasis in Obesity

References

• Hawkes JE, Yan BY, Chan TC, et al. Discovery of the IL-23/IL-17 signaling pathway and the treatment of psoriasis. J Immunol. 2018;201:1605–1613.
   PubMed Web of Science ®Google Scholar
• Costa L, Ramonda R, Ortolan A, et al. Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment. Clin Rheumatol. 2019;38:2355–2362.
   PubMed Web of Science ®Google Scholar
• Aune D, Snekvik I, Schlesinger S, et al. Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2018;33:1163–1178.
   PubMed Web of Science ®Google Scholar
• Budu-Aggrey A, Brumpton B, Tyrrell J, et al. Evidence of a causal relationship between body mass index and psoriasis: a Mendelian randomization study. PLoS Med. 2019;16:e1002739.
   PubMed Web of Science ®Google Scholar
• Paroutoglou K, Papadavid E, Christodoulatos GS, et al. Deciphering the association between psoriasis and obesity: current evidence and treatment considerations. Curr Obes Rep. 2020;9:165–178.
   PubMed Web of Science ®Google Scholar
• Ogawa K, Stuart PE, Tsoi LC, et al. A transethnic Mendelian randomization study identifies causality of obesity on risk of psoriasis. J Invest Dermatol. 2019;139:1397–1400.
   PubMed Web of Science ®Google Scholar
• Castaldo G, Rastrelli L, Galdo G, et al. Aggressive weight-loss program with a ketogenic induction phase for the treatment of chronic plaque psoriasis: a proof-of-concept, single-arm, open-label clinical trial. Nutrition. 2020;74:110757.
   PubMed Web of Science ®Google Scholar
• Jensen P, Christensen R, Zachariae C, et al. Long-term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow-up study. Am J Clin Nutr. 2016;104:259–265.
   PubMed Web of Science ®Google Scholar
• Upala S, Sanguankeo A. Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: a systematic review and meta-analysis. Int J Obes. 2015;39:1197–1202.
   PubMed Web of Science ®Google Scholar
• Mahil SK, McSweeney SM, Kloczko E, et al. Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A critically appraised topic. Br J Dermatol. 2019;181:946–953.
   PubMed Web of Science ®Google Scholar
• Wong Y, Nakamizo S, Tan KJ, Kabashima K. An Update on the role of adipose tissues in psoriasis. Front Immunol. 2019;10:1507.
   PubMed Web of Science ®Google Scholar
• Winer S, Paltser G, Chan Y, et al. Obesity predisposes to Th17 bias. Eur J Immunol. 2009;39:2629–2635.
   PubMed Web of Science ®Google Scholar
• Su X, Cheng Y, Chang D. The important role of leptin in modulating the risk of dermatological diseases. Front Immunol. 2021;11:593564.
   PubMed Web of Science ®Google Scholar
• Zhang AMY, Wellberg EA, Kopp JL, Johnson JD. Hyperinsulinemia in obesity, inflammation, and cancer. Diabetes Metab J. 2021;45:285–311.
   PubMed Web of Science ®Google Scholar
• Jung TW, Park HS, Choi GH. Kim D and Lee T: β-aminoisobutyric acid attenuates LPS-induced inflammation and insulin resistance in adipocytes through AMPK-mediated pathway. J Biomed Sci. 2018;25:27.
   PubMed Web of Science ®Google Scholar
• Wang X, Yao Y, Li Y, Guo S, Li Y, Zhang G. Experimental study on the effect of luteolin on the proliferation, apoptosis and expression of inflammation-related mediators in lipopolysaccharide-induced keratinocytes. Int J Immunopathol Pharmacol. 2023;37:3946320231169175.
   Web of Science ®Google Scholar
• Lao J, Xie Z, Qin Q, Qin R, Li S, Yuan Y. Serum LL-37 and inflammatory cytokines levels in psoriasis. Immun Inflamm Dis. 2023;11:e802.
   PubMed Web of Science ®Google Scholar
• Hao JQ. Targeting interleukin-22 in psoriasis. Inflammation. 2014;37:94–99. doi:10.1007/s10753-013-9715-y
   PubMed Web of Science ®Google Scholar
• Teng MW, Bowman EP, McElwee JJ, et al. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. Nat Med. 2015;21:719–729.
   PubMed Web of Science ®Google Scholar
• Yoshiki R, Kabashima K, Honda T, et al. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells. J Invest Dermatol. 2014;134:1912–1921.
   PubMed Web of Science ®Google Scholar
• Wohn C, Ober-Blöbaum JL, Haak S, et al. Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice. Proc Natl Acad Sci USA. 2013;110:10723–10728.
   PubMed Web of Science ®Google Scholar
• Arnold IC, Mathisen S, Schulthess J, et al. CD11c+ monocyte/macrophages promote chronic Helicobacter hepaticus-induced intestinal inflammation through the production of IL-23. Mucosal Immunol. 2016;9:352–363.
   PubMed Web of Science ®Google Scholar
• Piskin G, Sylva-Steenland RM, Bos JD, Teunissen MB. In-vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J Immunol. 2006;176:1908–1915.
   PubMed Web of Science ®Google Scholar
• Kochumon S, Hasan A, Al-Rashed F, et al. Increased adipose tissue expression of IL-23 associates with inflammatory markers in people with high LDL cholesterol. Cells. 2022;11:3072.
   PubMed Web of Science ®Google Scholar
• Pirowska M, Obtułowicz A, Lipko-Godlewska S, et al. The level of proinflammatory cytokines: interleukins 12, 23, 17 and tumor necrosis factor α in patients with metabolic syndrome accompanying severe psoriasis and psoriatic arthritis. Postepy Dermatol Alergol. 2018;35:360–366.
   PubMed Web of Science ®Google Scholar
• Sumarac-Dumanovic M, Stevanovic D, Ljubic A, et al. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes. 2009;33:151–156.
   PubMed Web of Science ®Google Scholar
• Kumar S, Han J, Li T, Qureshi AA. Obesity, waist circumference, weight change and the risk of psoriasis in US women. J Eur Acad Dermatol Venereol. 2013;27:1293–1298.
   PubMed Web of Science ®Google Scholar
• Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: nurses’ Health Study II. Arch Intern Med. 2007;167:1670–1675.
   PubMed Web of Science ®Google Scholar
• Scher JU, Ogdie A, Merola JF, et al. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019;15:153–166.
   PubMed Web of Science ®Google Scholar
• Kumthekar A, Ogdie A. Obesity and psoriatic arthritis: a narrative review. Rheumatol Ther. 2020;7:447–456.
   PubMed Web of Science ®Google Scholar
• Polachek A, Li S, Chandran V, Gladman DD. Clinical enthesitis in a prospective longitudinal psoriatic arthritis cohort: incidence, prevalence, characteristics, and outcome. Arthritis Care Res. 2017;69:1685–1691.
   PubMed Web of Science ®Google Scholar
• Higa-Sansone G, Szomstein S, Soto F, et al. Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg. 2004;14:1132–1134.
   PubMed Web of Science ®Google Scholar
• de Menezes Ettinger JE, Azaro E, de Souza CA, et al. Remission of psoriasis after open gastric bypass. Obes Surg. 2006;16:94–97.
   PubMed Web of Science ®Google Scholar
• Hossler EW, Wood GC, Still CD, et al. The effect of weight loss surgery on the severity of psoriasis. Br J Dermatol. 2013;168:660–661.
   PubMed Web of Science ®Google Scholar
• Singh S, Facciorusso A, Singh AG, et al. Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: a systematic review and meta-analysis. PLoS One. 2018;13:e0195123.
   PubMed Web of Science ®Google Scholar
• Mourad A, Straube S, Armijo-Olivo S, et al. Factors predicting persistence of biologic drugs in psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2019;181:450–458.
   PubMed Web of Science ®Google Scholar
• Naldi L, Conti A, Cazzaniga S, et al. Diet and physical exercise in psoriasis: a randomized controlled trial. Br J Dermatol. 2014;170:634–642.
   PubMed Web of Science ®Google Scholar
• Whitley SK, Li M, Kashem SW, et al. Local IL-23 is required for proliferation and retention of skin-resident memory TH17 cells. Sci Immunol. 2022;7:eabq3254.
   PubMed Web of Science ®Google Scholar
• Guilherme A, Virbasius JV, Puri V, et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9:367–377.
   PubMed Web of Science ®Google Scholar
• Wu CY, Shieh JJ, Shen JL, et al. Association between antidiabetic drugs and psoriasis risk in diabetic patients: results from a nationwide nested case-control study in Taiwan. J Am Acad Dermatol. 2015;72:123–130.
   PubMed Web of Science ®Google Scholar
• Krentz AJ, Friedmann PS. Type 2 diabetes, psoriasis and thiazolidinediones. Int J Clin Pract. 2006;60:362–363.
   PubMed Web of Science ®Google Scholar
• Tsuji G, Hashimoto-Hachiya A, Yen VH, et al. Metformin inhibits IL-1β secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis. Cell Death Discov. 2020;6:11.
   PubMed Web of Science ®Google Scholar
• Moore AF, Soper T, Jones N, et al. Psoriatic exacerbation associated with insulin therapy. Diabetes Care. 2008;31:e31.
   PubMedGoogle Scholar
• Wang P, Ran Y. Subcutaneous injection of isophane protamine biosynthetic human insulin induced psoriasis at the injection site. Eur J Dermatol. 2011;21:807–808.
   PubMed Web of Science ®Google Scholar
• Field S, Kelly G, Tobin AM, et al. Severe deterioration of psoriasis due to an insulinoma. Clin Exp Dermatol. 2008;33:145–147.
   PubMed Web of Science ®Google Scholar
• Cao J, Yee D. Disrupting Insulin and IGF Receptor Function in Cancer. Int J Mol Sci. 2021;22:555.
   PubMed Web of Science ®Google Scholar